(1S,2R,4S,5R)‐tert‐Butyl 7‐oxo‐3‐oxa‐6‐aza­tri­cyclo­[3.2.1.0^2,4]­octane‐6‐carboxyl­ate

By  

Acta Crystallographica Section E, Vol. 60, Iss. 12, 2004-12 ,pp. : o2515-o2516

John Wiley & Sons Inc

Access to resources Recommend Favorite

Molecular structure of (4Z)-{[(1R,6S)-7,7-dimethyl-2-oxo-3-oxabicyclo [4.1.0] hept-4-en-4-yl]methylene}-2-phenyl-l,3-oxazol-5(4H)-one

By Kasradze V.   Salimova E.   Galin F.   Kukovinets O.   Starikova Z.   Antipin M.  

Journal of Structural Chemistry, Vol. 51, Iss. 3, 2010-06 ,pp. : 599-602

Springer Publishing Company

Access to resources Recommend Favorite

[(1R,4aS)‐7‐Isopropyl‐1,4a‐dimethyl‐1,2,3,4,4a,9,10,10a‐octahydrophenanthren‐1‐yl](piperidin‐1‐yl)methanone

By  

Acta Crystallographica Section E, Vol. 63, Iss. 9, 2007-09 ,pp. : o3886-o3886

John Wiley & Sons Inc

Access to resources Recommend Favorite

The development of a practical synthesis of the potent and selective somatostatin sst 3 receptor antagonist [4-(3,4-difluoro-phenyl)-piperazine-1-yl]-{(4S,4aS,8aR)-2[(S)-3-(6-methoxy-p yridin-3-yl)-2-methyl-propyl]-decahydroisoquinoline-4-yl}-methanone (NVP-ACQ090)

By Banziger M.   Cercus J.   Hirt H.   Laumen K.   Malan C.   Spindler F.   Struber F.   Troxler T.  

Tetrahedron: Asymmetry, Vol. 14, Iss. 22, 2003-11 ,pp. : 3469-3477

Elsevier

Access to resources Recommend Favorite

(3′S,4R)‐3‐(3′‐Cyclo­pentyl‐3′‐phenyl­propano­yl)‐5,5‐dimethyl‐4‐phenyl‐1,3‐oxazolidin‐2‐one

By  

Acta Crystallographica Section E, Vol. 62, Iss. 11, 2006-11 ,pp. : o5132-o5133

John Wiley & Sons Inc

Access to resources Recommend Favorite